An epidemic oc gentamicin/cloxacillin resistant staphylococcal infection in a neonatal unit.
D000583:Amikacin / Q000627:therapeutic use*; D002981:Clindamycin / Q000627:therapeutic use*; D003023:Cloxacillin / Q000494:pharmacology / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy*; D005260:Female; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D007612:Kanamycin / Q000031:analogs & derivatives*; D008297:Male; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy; D011815:R Factors / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects
D005839:Gentamicins; D002981:Clindamycin; D007612:Kanamycin; D000583:Amikacin; D003023:Cloxacillin